Assessing User Fees Under the Generic Drug User Fee Amendments of 2022
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 9, 2023
June 8, 2023
f97fbaf6-3c85-4cbc-ac92-15d0649f8092
Related Documents
Competitive Generic Therapies
Guidance DocumentOctober 5, 2022Center for Drug Evaluation and Research
Assessing User Fees Under the Over-the-Counter Monograph Drug User Fee Program
Guidance DocumentNovember 1, 2022Center for Drug Evaluation and Research
Nonclinical Evaluation of the Immunotoxic Potential of Pharmaceuticals
Guidance DocumentJune 5, 2023Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox